VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMS 2022 | The MGP panel: a targeted genomics panel to identify cytogenetic abnormalities in multiple myeloma

Rafat Abonour, MD, Indiana University School of Medicine, Indianapolis, IN, comments on the potential of the MGP panel, a targeted sequencing panel to identify common cytogenetic abnormalities in multiple myeloma, suggesting this new panel may replace the use of fluorescence in situ hybridization (FISH). This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter